402 related articles for article (PubMed ID: 9060200)
1. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
[TBL] [Abstract][Full Text] [Related]
2. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
Hovda KE; Liberg JP; Nordby G; Jacobsen D
Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
[TBL] [Abstract][Full Text] [Related]
3. Gamma-hydroxybutyrate withdrawal syndrome.
Dyer JE; Roth B; Hyma BA
Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
[TBL] [Abstract][Full Text] [Related]
4. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
5. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
McDaniel CH; Miotto KA
J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
7. [Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].
Richter C; Romanowski A; Kienast T
Psychiatr Prax; 2009 Oct; 36(7):345-7. PubMed ID: 19173170
[TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyrate (GHB): a newer drug of abuse.
O'Connell T; Kaye L; Plosay JJ
Am Fam Physician; 2000 Dec; 62(11):2478-83. PubMed ID: 11130233
[TBL] [Abstract][Full Text] [Related]
9. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
Veerman SR; Dijkstra HN; Liefting-Kluft I
Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
[TBL] [Abstract][Full Text] [Related]
10. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
Glasper A; McDonough M; Bearn J
Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
[TBL] [Abstract][Full Text] [Related]
11. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia.
Kantrowitz JT; Citrome L; Javitt DC
Clin Ther; 2009 Jun; 31 Pt 1():1360-73. PubMed ID: 19698899
[TBL] [Abstract][Full Text] [Related]
12. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
[TBL] [Abstract][Full Text] [Related]
13. The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen.
van Nieuwenhuijzen PS; McGregor IS; Hunt GE
Neuroscience; 2009 Jan; 158(2):441-55. PubMed ID: 18996447
[TBL] [Abstract][Full Text] [Related]
14. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice.
Cook CD; Aceto MD; Coop A; Beardsley PM
Psychopharmacology (Berl); 2002 Feb; 160(1):99-106. PubMed ID: 11862379
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic-like effects of gamma-hydroxybutyric acid (GHB) in mice tested in the light-dark box.
Navarro JF; Dávila G; Pedraza C; Arias JL
Psicothema; 2008 Aug; 20(3):460-4. PubMed ID: 18674444
[TBL] [Abstract][Full Text] [Related]
16. [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)].
Iten PX; Oestreich A; Lips R; Brabetz M
Schweiz Med Wochenschr; 2000 Mar; 130(10):356-61. PubMed ID: 10763213
[TBL] [Abstract][Full Text] [Related]
17. Gamma-hydroxybutyrate detoxification by titration and tapering.
de Jong CA; Kamal R; Dijkstra BA; de Haan HA
Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
[TBL] [Abstract][Full Text] [Related]
18. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
[TBL] [Abstract][Full Text] [Related]
19. The clinical development of gamma-hydroxybutyrate (GHB).
Wedin GP; Hornfeldt CS; Ylitalo LM
Curr Drug Saf; 2006 Jan; 1(1):99-106. PubMed ID: 18690919
[TBL] [Abstract][Full Text] [Related]
20. Gamma-hydroxybutyrate--a drug of abuse.
Drasbek KR; Christensen J; Jensen K
Acta Neurol Scand; 2006 Sep; 114(3):145-56. PubMed ID: 16911342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
